Can hip shape help predict fractures in women?
As we age, our bones can become more fragile, making fractures even from minor incidents – like a simple fall – more likely. These are known as fragility fractures,...
Medical research that works, together
At Deakin’s School of Medicine, The Institute for Mental and Physical Health and Clinical Translation (IMPACT) develops new and effective responses to mental and physical health for our community. We use cutting-edge approaches to translate our medical research from the laboratory to real-world solutions.
Find out moreAbout us
Our team of over 300 researchers has a shared aim to improve the quality of life of our global community. We work to develop innovative diagnostics, treatments and therapies for mental health conditions and chronic diseases.
Our multi-disciplinary, collaborative and responsive approach allows us to quickly translate our biomedical discoveries, made at the science lab bench, into treatment possibilities at the bedside of our trial patients and the broader community.
Find out more
What we do
Cells
In our state-of-the-art biomedical and clinical research labs, we explore the molecular basis of health and disease, such as basic gene discovery and molecular analysis.
Body
We explore the complex interrelation between mental and physical health, including identifying and modifying factors in our environment, diet and chronic diseases.
Mind
We work to find new approaches to treating mental health disorders such as depression and bipolar disorder by discovering novel drugs or repurposing pre-existing ones used for other conditions.
Want to find out more?
See what we've been up to lately
Trials of new point of care tests to help reduce overuse of antibiotics
Researchers at Deakin University are leading Geelong based trials of two new tests for bacterial infection that have the potential to significantly reduce the overuse of antibiotics prescribed to...
NHMRC funding: Exploring new approaches to target the malaria parasite
Malaria parasites are becoming increasingly resistant to current treatments, including the front-line drug Artemisinin, highlighting the urgent need for a new approach. Researchers from Deakin University’s Institute for Mental...
Looking for some more good news?
Find out moreSubscribe
Stay updated on the latest from IMPACT by subscribing to our newsletter.